Metabolites
Displaying compounds 12026 - 12050 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12322 | CDP-DG(16:0/22:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(docosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H93N3O15P2 1038.248 | |
| YMDB12323 | CDP-DG(16:0/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12324 | CDP-DG(16:0/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-docos-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12325 | CDP-DG(16:0/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12326 | CDP-DG(16:0/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12327 | CDP-DG(16:0/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(tetracosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H97N3O15P2 1066.302 | |
| YMDB12328 | CDP-DG(16:0/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-tetracos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12329 | CDP-DG(16:0/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-tetracos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12330 | CDP-DG(16:0/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(pentacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H99N3O15P2 1080.329 | |
| YMDB12331 | CDP-DG(16:0/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-pentacos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H97N3O15P2 1078.313 | |
| YMDB12332 | CDP-DG(16:0/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-pentacos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H97N3O15P2 1078.313 | |
| YMDB12333 | CDP-DG(16:0/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(hexacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H101N3O15P2 1094.356 | |
| YMDB12334 | CDP-DG(16:0/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(12Z)-hexacos-12-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
| YMDB12335 | CDP-DG(16:0/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(10Z)-heptacos-10-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12336 | CDP-DG(16:0/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H103N3O15P2 1108.383 | |
| YMDB12337 | CDP-DG(16:0/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12338 | CDP-DG(16:0/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12339 | CDP-DG(16:0/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(octacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H105N3O15P2 1122.41 | |
| YMDB12340 | CDP-DG(16:0/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(12Z)-octacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
| YMDB12341 | CDP-DG(16:0/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(10Z)-octacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
| YMDB12342 | CDP-DG(16:0/29:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(nonacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H107N3O15P2 1136.437 | |
| YMDB12343 | CDP-DG(16:0/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(triacontanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H109N3O15P2 1150.464 | |
| YMDB12344 | CDP-DG(16:1(11Z)/16:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis[(11Z)-hexadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H77N3O15P2 950.054 | |
| YMDB12345 | CDP-DG(16:1(11Z)/16:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H77N3O15P2 950.054 | |
| YMDB12346 | CDP-DG(16:1(11Z)/18:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-(octadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H83N3O15P2 980.124 |